~ 100311 The Silent Epidemic of Iodine Deficiency - References


1. Dasgupta PK, Liu Y, Dyke JV. Iodine nutrition: iodine content of iodized salt in the United States. Environ Sci Technol. 2008 Feb 15;42(4):1315-23.

2. Dasgupta PK, Liu Y, Dyke JV. Iodine nutrition: iodine content of iodized salt in the United States. Environ Sci Technol. 2008 Feb 15;42(4):1315-23.

3. Gunton JE, Hams G, Fiegert M, McElduff A. Iodine deficiency in ambulatory participants at a Sydney teaching hospital: is Australia truly iodine replete? Med J Aust. 1999 Nov 1;171(9):467-70.

4. Hoption Cann SA. Hypothesis: dietary iodine intake in the etiology of cardiovascular disease. J Am Coll Nutr. 2006 Feb;25(1):1-11.

5. Kapil U, Sharma TD, Singh P, Dwivedi SN, Kaur S. Thirty years of a ban on the sale of noniodized salt: impact on iodine nutrition in children in Himachal Pradesh, India. Food Nutr Bull. 2005 Sep;26(3):255-8.

6. Dunn JT. Seven deadly sins in confronting endemic iodine deficiency, and how to avoid them. J Clin Endocrinol Metab. 1996 Apr;81(4):1332-5.

7. McClure RD. Goiter prophylaxis with iodized salt. Science. 1935 Oct 18;82(2129):3701.

8. Darcan S, Goksen D. Consequences of iodine deficiency and preventive measures. Pediatr Endocrinol Rev. 2003 Dec;1 Suppl 2:162-8; discussion 68-9.

9. Szybinski Z, Jarosz M, Hubalewska-Dydejczyk A, et al. Iodine-deficiency prophylaxis and the restriction of salt consumption - a 21st century challenge. Endokrynol Pol. 2010 Jan-Feb;61(1):135-40.

10. Zimmermann MB. Iodine deficiency. Endocr Rev. 2009 Jun;30(4):376-408.

11. Triggiani V, Tafaro E, Giagulli VA, et al. Role of iodine, selenium and other micronutrients in thyroid function and disorders. Endocr Metab Immune Disord Drug Targets. 2009 Sep;9(3):277-94.

12. Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18;362(7):590-9.

13. Titze J, Ritz E. Salt and its effect on blood pressure and target organ damage: new pieces in an old puzzle. J Nephrol. 2009 Mar-Apr;22(2):177-89.

14. Caldwell KL, Jones R, Hollowell JG. Urinary iodine concentration: United States National Health And Nutrition Examination Survey 2001-2002. Thyroid. 2005 Jul;15(7):692-9.

15. Wang GY, Zhou RH, Wang Z, Shi L, Sun M. Effects of storage and cooking on the iodine content in iodized salt and study on monitoring iodine content in iodized salt. Biomed Environ Sci. 1999 Mar;12(1):1-9.

16. Krajcovicova-Kudlackova M, Buckova K, Klimes I, Sebokova E. Iodine deficiency in vegetarians and vegans. Ann Nutr Metab. 2003;47(5):183-5.

17. Smyth PP, Duntas LH. Iodine uptake and loss-can frequent strenuous exercise induce iodine deficiency? Horm Metab Res. 2005 Sep;37(9):555-8.

18. Patrick L. Iodine: deficiency and therapeutic considerations. Altern Med Rev. 2008 Jun;13(2):116-27.

19. Baier-Anderson C, Blount BC, Lakind JS, Naiman DQ, Wilbur SB, Tan S. Estimates of exposures to perchlorate from consumption of human milk, dairy milk, and water, and comparison to current reference dose. J Toxicol Environ Health A. 2006 Feb;69(3-4):319-30.

20. Sanchez CA, Krieger RI, Khandaker N, Moore RC, Holts KC, Neidel LL. Accumulation and perchlorate exposure potential of lettuce produced in the Lower Colorado River region. J Agric Food Chem. 2005 Jun 29;53(13):5479-86.

21. Snyder SA, Pleus RC, Vanderford BJ, Holady JC. Perchlorate and chlorate in dietary supplements and flavor enhancing ingredients. Anal Chim Acta. 2006 May 10;567(1):26-32.

22. Greer MA, Goodman G, Pleus RC, Greer SE. Health effects assessment for environmental perchlorate contamination: the dose response for inhibition of thyroidal radioiodine uptake in humans. Environ Health Perspect. 2002 Sep;110(9):927-37.

23. Available at: http://lpi.oregonstate.edu/infocenter/minerals/iodine/. Accessed July 18, 2011.

24. Available at: http://emedicine.medscape.com/article/122714-overview. Accessed July 18, 2011.

25. Cann SA, van Netten JP, van Netten C. Hypothesis: iodine, selenium and the development of breast cancer. Cancer Causes Control. 2000 Feb;11(2):121-7.

26. Nagataki S, Shizume K, Nakao K. Thyroid function in chronic excess iodide ingestion: comparison of thyroidal absolute iodine uptake and degradation of thyroxine in euthyroid Japanese subjects. J Clin Endocrinol Metab. 1967 May;27(5):638-47.

27. Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ, Ozden M. Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Endocr Res. 2003 Aug;29(3):307-16.

28. Iqbal A, Jorde R, Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. J Intern Med. 2006 Jul;260(1):53-61.

29. Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res. 2004;59:31-50.

30. Canaris GJ, Steiner JF, Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med. 1997 Sep;12(9):544-50.

31. Wartofsky L. Management of subclinical hyperthyroidism. J Clin Endocrinol Metab. 2011 Jan;96(1):59-61.

32. Kramer CK, Von Muhlen D, Kritz-Silverstein D, Barrett-Connor E. Treated hypothyroidism, depressed mood, and cognitive function in old age: the Rancho Bernardo Study. Eur J Endocrinol. 2009 Dec; 161(6):917-21

33. Zimmermann MB. Iodine deficiency in pregnancy and the effects of maternal iodine supplementation on the offspring: a review. Am J Clin Nutr. 2009 Feb;89(2):668S-72S.

34. Verheesen RH, Schweitzer CM. Iodine deficiency, more than cretinism and goiter. Med Hypotheses. 2008 Nov;71(5):645-8.

35. Laurberg P, Nohr SB, Pedersen KM, et al. Thyroid disorders in mild iodine deficiency. Thyroid. 2000 Nov;10(11):951-63.

36. Bretthauer EW, Mullen AL, Moghissi AA. Milk transfer comparisons of different chemical forms of radioiodine. Health Phys. 1972 Mar;22(3):257-60.

37. Spitzweg C, Harrington KJ, Pinke LA, Vile JG, Morris JC. Clinical review 132: the sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab 2001 Jul;86(7):3327-35.

38. Kilbane MT, Ajjan RA, Weetman AP, et al. Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer. J Clin Endocrinol Metab. 2000 Mar;85(3):1245-50.

39. Topper YJ, Freeman CS. Multiple hormone interactions in the developmental biology of the mammary gland. Physiol Rev 1980 Oct;60(4):1049-106

40. Eskin BA. Iodine and mammary cancer. Adv Exp Med Biol. 1977;91:293-304.

41. Smyth PP. Role of iodine in antioxidant defence in thyroid and breast disease. Biofactors. 2003;19(3-4):121-30.

42. Venturi S, Donati FM, Venturi A, Venturi M, Grossi L, Guidi A. Role of iodine in evolution and carcinogenesis of thyroid, breast and stomach. Adv Clin Path. 2000 Jan;4(1):11-7.

43. Venturi S. Is there a role for iodine in breast diseases? Breast. 2001 Oct;10(5):379-82.

44. Stadel BV. Dietary iodine and risk of breast, endometrial, and ovarian cancer. Lancet. 1976 Apr 24;1(7965):890-1.

45. Many MC, Papadopolos C, Martin I, et al. Iodine induced cell damage in mouse hyperplastic thyroid is associated with lipid peroxidation. In: Gordon A, Gross J, Hennemann G, eds. Progress in Thyroid Research. New York, NY: Routledge; 1991:213-5.

46. Nolan LA, Windle RJ, Wood SA, et al. Chronic iodine deprivation attenuates stress-induced and diurnal variation in corticosterone secretion in female Wistar rats. J Neuroendocrinol. 2000 Dec;12(12):1149-59.

47. Stolc V. Stimulation of iodoproteins and thyroxine formation in human leukocytes by phagocytosis. Biochem Biophys Res Commun. 1971 Oct 1;45(1):159-66.

48. Cohen M, Klein E, Kuten A, Fried G, Zinder O, Pollack S. Increased emotional distress in daughters of breast cancer patients is associated with decreased natural cytotoxic activity, elevated levels of stress hormones and decreased secretion of Th1 cytokines. Int J Cancer. 2002 Jul 20;100(3):347-54.

49. Inaudi P, Bernabei A, Gioffre W, et al. Plasma and cyst fluid levels of delta 5 and delta 4 steroid hormones in women with gross cystic breast disease. Clin Endocrinol (Oxf). 1987 Dec;27(6):643-8.

50. James GD, Gastrich HJ, Valdimarsdottir HB, Bovbjerg DH. The rate of urinary cortisol excretion at work is persistently elevated in women at familial risk for breast cancer. Am J Hum Biol. 2008 Jul-Aug;20(4):478-80.

51. Thornton LM, Andersen BL, Carson WE, 3rd. Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis. Cancer Immunol Immunother. 2008 Oct;57(10):1471-81.

52. Smyth PP. The thyroid, iodine and breast cancer. Breast Cancer Res. 2003;5(5):235-8.

53. Smyth PP. Thyroid disease and breast cancer. J Endocrinol Invest. 1993 May;16(5):396-401.

54. Aceves C, Anguiano B, Delgado G. Is iodine a gatekeeper of the integrity of the mammary gland? J Mammary Gland Biol Neoplasia. 2005 Apr;10(2):189-96.

55. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993 Nov 17;85(22):1819-27.

56. Garcia-Solis P, Alfaro Y, Anguiano B, et al. Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I-) treatment Evidence that I2 prevents cancer promotion. Mol Cell Endocrinol. 2005 May 31;236(1-2):49-57.

57. Funahashi H, Imai T, Tanaka Y, et al. Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat. J Surg Oncol. 1996 Mar;61(3):209-13.

58. Shrivastava A, Tiwari M, Sinha RA, et al. Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. J Biol Chem. 2006 Jul 14;281(28):19762-71.

59. Goehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev. 1997;19(2):310-27.

60. Krouse TB, Eskin BA, Mobini J. Age-related changes resembling fibrocystic disease in iodine-blocked rat breasts. Arch Pathol Lab Med. 1979 Nov;103(12):631-4.

61. Eskin BA, Grotkowski CE, Connolly CP, Ghent WR. Different tissue responses for iodine and iodide in rat thyroid and mammary glands. Biol Trace Elem Res. 1995 Jul;49(1):9-19.

62. Ghent WR, Eskin BA, Low DA, Hill LP. Iodine replacement in fibrocystic disease of the breast. Can J Surg. 1993 Oct;36(5):453-60.

63. Kahaly GJ. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid. 2000 Aug;10(8):665-79.

64. Park YJ, Lee YJ, Choi SI, Chun EJ, Jang HC, Chang HJ. Impact of subclinical hypothyroidism on the coronary artery disease in apparently healthy subjects. Eur J Endocrinol. 2011 Jul;165(1):115-21.

65. Haentjens P, Van Meerhaeghe A, Poppe K, Velkeniers B. Subclinical thyroid dysfunction and mortality: An estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur J Endocrinol. 2008 Sep;159(3):329-41.

66. Rizos CV, Elisaf MS, Liberopoulos EN. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011;5:76-84.

67. Molnar I, Magyari M, Stief L. Iodine deficiency in cardiovascular diseases. Orv Hetil. 1998 Aug 30;139(35):2071-3.

68. Jung CH, Sung KC, Shin HS, et al. Thyroid dysfunction and their relation to cardiovascular risk factors such as lipid profile, hsCRP, and waist hip ratio in Korea. Korean J Intern Med. 2003 Sep;18(3):146-53.

69. Mariotti S, Cambuli VM. Cardiovascular risk in elderly hypothyroid patients. Thyroid. 2007 Nov;17(11):1067-73.

70. Venturi S, Venturi M. Iodine in evolution of salivary glands and in oral health. Nutr Health. 2009;20(2):119-34.

71. Abnet CC, Fan JH, Kamangar F, et al. Self-reported goiter is associated with a significantly increased risk of gastric noncardia adenocarcinoma in a large population-based Chinese cohort. Int J Cancer. 2006 Sep 15;119(6):1508-10.

72. Behrouzian R, Aghdami N. Urinary iodine/creatinine ratio in patients with stomach cancer in Urmia, Islamic Republic of Iran. East Mediterr Health J. 2004 Nov;10(6):921-4.

73. Gulaboglu M, Yildiz L, Celebi F, Gul M, Peker K. Comparison of iodine contents in gastric cancer and surrounding normal tissues. Clin Chem Lab Med. 2005;43(6):581-4.

74. Golkowski F, Szybinski Z, Rachtan J, et al. Iodine prophylaxis--the protective factor against stomach cancer in iodine deficient areas. Eur J Nutr. 2007 Aug;46(5):251-6.

75. Kupper FC, Carpenter LJ, McFiggans GB, et al. Iodide accumulation provides kelp with an inorganic antioxidant impacting atmospheric chemistry. Proc Natl Acad Sci U S A. 2008 May 13;105(19):6954-8.

Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.

While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.